NCT02666937

Brief Summary

A study consisting of a prospective and retrospective cohort in the ICU, ER and pulmonary department in a university hospital in Amsterdam and a teaching hospital in Alkmaar, the Netherlands. The relationship between the oxygen saturation measured by pulse-oximetry and the arterial PaO2 is investigated in order to investigate which transcutaneous saturation values are safe when administering oxygen in relation to hyperopia and hypoxia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
879

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2015

Completed
1 day until next milestone

Study Start

First participant enrolled

December 1, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 28, 2016

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

October 18, 2018

Status Verified

October 1, 2018

Enrollment Period

1.7 years

First QC Date

November 30, 2015

Last Update Submit

October 16, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Relation SpO2-PaO2

    To determine peripherally measured saturation targets between which no hyperoxia and hypoxia will occur

    Average of one week

Secondary Outcomes (3)

  • Factors influencing PaO2-Spo2 relation

    Average of one week

  • Relation in SpO2-PaO2 in different populations

    Average of one week

  • Differences in relation in SpO2-PaO2 prospective versus retrospective

    Average of one week

Study Arms (4)

ICU-patients (prospective)

Critically ill patients (18 years and older) on mechanically ventilation who have an arterial line and require bloodgasanalysis for medical reasons

Emergency Department (prospective)

Patients (18 years and older), who are presented to the Emergency Department, and require bloodgasanalysis for medical reasons

Pulmonary department (prospective)

Patients (18 years and older) who visit the outpatient clinic of the pulmonary department for different pulmonary functional test and require bloodgasanalysis for medical reasons

Pulmonary department (retrospective)

Patients (18 years and older) who visited the outpatient clinic of the pulmonary department in the past of the VU medical centre in Amsterdam or the Medical Centre Alkmaar for different pulmonary functional test and required bloodgasanalysis for medical reasons

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Prospective * ICU - VUmc: Critically ill patients, requiring invasive monitoring * Pulmonary function department - VUmc: Patients requiring a pulmonary function test with arterial bloodgas analysis. * ER VUmc: Patients presented at the shockroom or patients in the general ER, requiring arterial bloodgas analysis. Retrospective \- Pulmonary function departments: Patients who underwent a pulmonary function test with arterial bloodgas analysis in the last 25 years.

You may qualify if:

  • Age: 18\>
  • Requiring arterial bloodgas analysis

You may not qualify if:

  • Hyperbilirubinemia (\>20 μmol/L)
  • CO-Hb (\>1,5%)
  • MetHb (\>1,5%)
  • Unreliable pulsatile SpO2 curve
  • \- Prospective, ICU - VUmc: On mechanical ventilation. Arterial line in place.
  • Prospective, ICU - VUmc: On extracorporeal membrane oxygenation. Therapeutic hypothermia.
  • Retrospective, Pulmonary function departments: Uncertainty whether SpO2 was measured exactly during arterial bloodgas sampling.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VUMedicalCentre

Amsterdam, North Holland, 1007 MB, Netherlands

Location

Related Publications (29)

  • Cornet AD, Kooter AJ, Peters MJ, Smulders YM. Supplemental oxygen therapy in medical emergencies: more harm than benefit? Arch Intern Med. 2012 Feb 13;172(3):289-90. doi: 10.1001/archinternmed.2011.624. Epub 2012 Jan 9. No abstract available.

    PMID: 22231614BACKGROUND
  • de Jonge E, Peelen L, Keijzers PJ, Joore H, de Lange D, van der Voort PH, Bosman RJ, de Waal RA, Wesselink R, de Keizer NF. Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients. Crit Care. 2008;12(6):R156. doi: 10.1186/cc7150. Epub 2008 Dec 10.

    PMID: 19077208BACKGROUND
  • Austin MA, Wills KE, Blizzard L, Walters EH, Wood-Baker R. Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ. 2010 Oct 18;341:c5462. doi: 10.1136/bmj.c5462.

    PMID: 20959284BACKGROUND
  • Kilgannon JH, Jones AE, Shapiro NI, Angelos MG, Milcarek B, Hunter K, Parrillo JE, Trzeciak S; Emergency Medicine Shock Research Network (EMShockNet) Investigators. Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. JAMA. 2010 Jun 2;303(21):2165-71. doi: 10.1001/jama.2010.707.

    PMID: 20516417BACKGROUND
  • Kuisma M, Boyd J, Voipio V, Alaspaa A, Roine RO, Rosenberg P. Comparison of 30 and the 100% inspired oxygen concentrations during early post-resuscitation period: a randomised controlled pilot study. Resuscitation. 2006 May;69(2):199-206. doi: 10.1016/j.resuscitation.2005.08.010. Epub 2006 Feb 24.

    PMID: 16500018BACKGROUND
  • Bellomo R, Bailey M, Eastwood GM, Nichol A, Pilcher D, Hart GK, Reade MC, Egi M, Cooper DJ; Study of Oxygen in Critical Care (SOCC) Group. Arterial hyperoxia and in-hospital mortality after resuscitation from cardiac arrest. Crit Care. 2011;15(2):R90. doi: 10.1186/cc10090. Epub 2011 Mar 8.

    PMID: 21385416BACKGROUND
  • Meyhoff CS, Jorgensen LN, Wetterslev J, Christensen KB, Rasmussen LS; PROXI Trial Group. Increased long-term mortality after a high perioperative inspiratory oxygen fraction during abdominal surgery: follow-up of a randomized clinical trial. Anesth Analg. 2012 Oct;115(4):849-54. doi: 10.1213/ANE.0b013e3182652a51. Epub 2012 Jul 13.

    PMID: 22798533BACKGROUND
  • Quintard H, Patet C, Suys T, Marques-Vidal P, Oddo M. Normobaric hyperoxia is associated with increased cerebral excitotoxicity after severe traumatic brain injury. Neurocrit Care. 2015 Apr;22(2):243-50. doi: 10.1007/s12028-014-0062-0.

    PMID: 25168744BACKGROUND
  • Rincon F, Kang J, Maltenfort M, Vibbert M, Urtecho J, Athar MK, Jallo J, Pineda CC, Tzeng D, McBride W, Bell R. Association between hyperoxia and mortality after stroke: a multicenter cohort study. Crit Care Med. 2014 Feb;42(2):387-96. doi: 10.1097/CCM.0b013e3182a27732.

    PMID: 24164953BACKGROUND
  • Baleeiro CE, Wilcoxen SE, Morris SB, Standiford TJ, Paine R 3rd. Sublethal hyperoxia impairs pulmonary innate immunity. J Immunol. 2003 Jul 15;171(2):955-63. doi: 10.4049/jimmunol.171.2.955.

    PMID: 12847267BACKGROUND
  • Davis WB, Rennard SI, Bitterman PB, Crystal RG. Pulmonary oxygen toxicity. Early reversible changes in human alveolar structures induced by hyperoxia. N Engl J Med. 1983 Oct 13;309(15):878-83. doi: 10.1056/NEJM198310133091502.

    PMID: 6888481BACKGROUND
  • Jackson RM. Pulmonary oxygen toxicity. Chest. 1985 Dec;88(6):900-5. doi: 10.1378/chest.88.6.900.

    PMID: 3905287BACKGROUND
  • Fracica PJ, Knapp MJ, Piantadosi CA, Takeda K, Fulkerson WJ, Coleman RE, Wolfe WG, Crapo JD. Responses of baboons to prolonged hyperoxia: physiology and qualitative pathology. J Appl Physiol (1985). 1991 Dec;71(6):2352-62. doi: 10.1152/jappl.1991.71.6.2352.

    PMID: 1778933BACKGROUND
  • Harten JM, Anderson KJ, Angerson WJ, Booth MG, Kinsella J. The effect of normobaric hyperoxia on cardiac index in healthy awake volunteers. Anaesthesia. 2003 Sep;58(9):885-8. doi: 10.1046/j.1365-2044.2003.03333.x.

    PMID: 12911363BACKGROUND
  • Lodato RF. Decreased O2 consumption and cardiac output during normobaric hyperoxia in conscious dogs. J Appl Physiol (1985). 1989 Oct;67(4):1551-9. doi: 10.1152/jappl.1989.67.4.1551.

    PMID: 2793757BACKGROUND
  • Haque WA, Boehmer J, Clemson BS, Leuenberger UA, Silber DH, Sinoway LI. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol. 1996 Feb;27(2):353-7. doi: 10.1016/0735-1097(95)00474-2.

    PMID: 8557905BACKGROUND
  • Zwemer CF, Whitesall SE, D'Alecy LG. Cardiopulmonary-cerebral resuscitation with 100% oxygen exacerbates neurological dysfunction following nine minutes of normothermic cardiac arrest in dogs. Resuscitation. 1994 Mar;27(2):159-70. doi: 10.1016/0300-9572(94)90009-4.

    PMID: 8086011BACKGROUND
  • O'Driscoll BR, Howard LS, Davison AG; British Thoracic Society. BTS guideline for emergency oxygen use in adult patients. Thorax. 2008 Oct;63 Suppl 6:vi1-68. doi: 10.1136/thx.2008.102947. No abstract available.

    PMID: 18838559BACKGROUND
  • Decalmer S, O'Driscoll BR. Oxygen: friend or foe in peri-operative care? Anaesthesia. 2013 Jan;68(1):8-12. doi: 10.1111/anae.12088. Epub 2012 Nov 7. No abstract available.

    PMID: 23130783BACKGROUND
  • Suzuki S, Eastwood GM, Glassford NJ, Peck L, Young H, Garcia-Alvarez M, Schneider AG, Bellomo R. Conservative oxygen therapy in mechanically ventilated patients: a pilot before-and-after trial. Crit Care Med. 2014 Jun;42(6):1414-22. doi: 10.1097/CCM.0000000000000219.

    PMID: 24561566BACKGROUND
  • Sinex JE. Pulse oximetry: principles and limitations. Am J Emerg Med. 1999 Jan;17(1):59-67. doi: 10.1016/s0735-6757(99)90019-0.

    PMID: 9928703BACKGROUND
  • Nitzan M, Romem A, Koppel R. Pulse oximetry: fundamentals and technology update. Med Devices (Auckl). 2014 Jul 8;7:231-9. doi: 10.2147/MDER.S47319. eCollection 2014.

    PMID: 25031547BACKGROUND
  • Swain DP, Pittman RN. Oxygen exchange in the microcirculation of hamster retractor muscle. Am J Physiol. 1989 Jan;256(1 Pt 2):H247-55. doi: 10.1152/ajpheart.1989.256.1.H247.

    PMID: 2912188BACKGROUND
  • Jensen LA, Onyskiw JE, Prasad NG. Meta-analysis of arterial oxygen saturation monitoring by pulse oximetry in adults. Heart Lung. 1998 Nov-Dec;27(6):387-408. doi: 10.1016/s0147-9563(98)90086-3.

    PMID: 9835670BACKGROUND
  • Astiz ME, Rackow EC, Kaufman B, Falk JL, Weil MH. Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction. Crit Care Med. 1988 Jul;16(7):655-8. doi: 10.1097/00003246-198807000-00001.

    PMID: 3371040BACKGROUND
  • van Genderen ME, Lima A, Bakker J, van Bommel J. [Peripheral circulation in critically ill patients: non-invasive methods for the assessment of the peripheral perfusion]. Ned Tijdschr Geneeskd. 2013;157(9):A5338. Dutch.

    PMID: 23446154BACKGROUND
  • House JR, Tipton MJ. Using skin temperature gradients or skin heat flux measurements to determine thresholds of vasoconstriction and vasodilatation. Eur J Appl Physiol. 2002 Nov;88(1-2):141-5. doi: 10.1007/s00421-002-0692-3. Epub 2002 Sep 3.

    PMID: 12436282BACKGROUND
  • Sessler DI. Skin-temperature gradients are a validated measure of fingertip perfusion. Eur J Appl Physiol. 2003 May;89(3-4):401-2; author reply 403-4. doi: 10.1007/s00421-003-0812-8. Epub 2003 Mar 25. No abstract available.

    PMID: 12736848BACKGROUND
  • Durlinger EMJ, Spoelstra-de Man AME, Smit B, de Grooth HJ, Girbes ARJ, Oudemans-van Straaten HM, Smulders YM. Hyperoxia: At what level of SpO2 is a patient safe? A study in mechanically ventilated ICU patients. J Crit Care. 2017 Jun;39:199-204. doi: 10.1016/j.jcrc.2017.02.031. Epub 2017 Mar 2.

    PMID: 28279497BACKGROUND

MeSH Terms

Conditions

Critical IllnessHyperoxiaHypoxia

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratorySigns and Symptoms

Study Officials

  • Angelique ME Spoelstra - de Man, Phd Md

    Amsterdam UMC, location VUmc

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. A.M.E. Spoelstra--de Man

Study Record Dates

First Submitted

November 30, 2015

First Posted

January 28, 2016

Study Start

December 1, 2015

Primary Completion

August 1, 2017

Study Completion

August 1, 2017

Last Updated

October 18, 2018

Record last verified: 2018-10

Locations